Ruxolitinib Sandoz 5 mg
Ruxolitinib Sandoz 5 mg is a medicine authorised by Swissmedic under authorisation number 70733. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 May 2026 and the authorisation is limited until 03 May 2031. ATC code L01EJ01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70733 |
|---|---|
| Name | Ruxolitinib Sandoz 5 mg |
| Full name | Ruxolitinib Sandoz 5 mg, Tabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EJ01 |
| First authorisation | 04 May 2026 |
| Authorisation validity | 03 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ruxolitinib Sandoz 5 mg, Tabletten | A | 04 May 2026 |
| 2 | Ruxolitinib Sandoz 10 mg, Tabletten | A | 04 May 2026 |
| 3 | Ruxolitinib Sandoz 15 mg, Tabletten | A | 04 May 2026 |
| 4 | Ruxolitinib Sandoz 20 mg, Tabletten | A | 04 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 2 | 168 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 3 | 56 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 4 | 168 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 5 | 56 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 6 | 168 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 7 | 56 | Tablette(n) | L01EJ01 | 07.16.1. | A |
| 8 | 168 | Tablette(n) | L01EJ01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ruxolitinib Sandoz 5 mg authorised in Switzerland?
Yes. Ruxolitinib Sandoz 5 mg is authorised by Swissmedic under authorisation number 70733, data as of 01 September 2026. The authorisation is limited until 03 May 2031.
Which dispensing category does Ruxolitinib Sandoz 5 mg have?
Ruxolitinib Sandoz 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ruxolitinib Sandoz 5 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.